Clinical trial
Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
NCT00043264
Study timeline
Registry last updated2005-06-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
RifampinDRUG · verified · RxNorm: rifampin
AzithromycinDRUG · verified · RxNorm: azithromycin
Sponsors & collaborators
National Center for Research Resources (NCRR)lead sponsor
National Multiple Sclerosis Societycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00043264 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.